Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,401,781
+$2,580,268 QoQ
Shares Held
9,506
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#1,187
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 49%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Smithfield Trust Co holds $61,006,231 across 17 Drug Manufacturers - General names. LLY ranks #3 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
79,661 | $20,231,503 | |
| 2 | MRK |
Merck & Co., Inc.
|
92,939 | $11,942,661 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
9,506 | $11,401,781 | |
| 4 | ABBV |
AbbVie Inc.
|
31,546 | $7,938,235 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,766 | $4,480,876 | |
| 6 | AMGN |
Amgen Inc
|
6,994 | $2,532,667 | |
| 7 | PFE |
Pfizer Inc
|
66,244 | $1,595,154 | |
| 8 | AZN |
Astrazeneca PLC
|
2,117 | $401,425 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,401,781 | 9,506 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $8,821,513 | 9,591 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $10,136,381 | 9,432 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,966,953 | 9,131 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $7,120,226 | 9,134 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $7,543,861 | 9,134 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $7,124,016 | 9,228 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $8,197,602 | 9,253 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,422,749 | 9,303 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $7,304,266 | 9,389 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,612,353 | 9,628 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $5,014,644 | 9,336 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,368,079 | 9,314 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $3,148,130 | 9,167 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,369,385 | 9,210 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,978,053 | 9,210 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,064,621 | 9,452 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,685,290 | 9,377 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,292,348 | 8,299 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,917,483 | 8,299 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,904,786 | 8,299 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,548,176 | 8,287 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,427,204 | 8,453 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,378,065 | 9,310 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,503,560 | 9,158 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,227,949 | 8,852 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||